In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...

The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

People with severe vision loss have been able to read again, thanks to a tiny wireless chip implanted in one of their eyes ...

Do you have blue eyes? We talked to experts to discover curious facts about baby blues. Like, are all blue-eyed people ...

By reducing inflammation, the researchers were able to prevent both the buildup of immune cells and the formation of these ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...